Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240249 | 1.00 | ALDH1A1 (0.65) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL8951105 | 1.00 | ALDH1A1 (0.65) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL30822463 | 1.00 | ALDH1A1 (0.65) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL12543741 | 1.00 | ALDH1A1 (0.65) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL14984822 | 0.98 | ALDH1A1 (0.61) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL637189 | 0.92 | ALDH1A1 (0.53) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL2422217 | 0.89 | ALDH1A1 (0.65) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL21068702 | 0.85 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL31307952 | 0.85 | HSD17B10 (0.49) | ALDH1A1LMNAMAPTTSHRCYP3A4 | |
| SCHEMBL1101944 | 0.84 | LMNA (0.42) | ALDH1A1LMNAMAPTABCC4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190284152-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-09-19 | — | — | US | disclosed |
| US-10294210-B2 | Maleinated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20180111912-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-04-26 | — | — | US | disclosed |
| US-9896424-B2 | Methods of making sulfurized derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-9738618-B2 | Malienated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2017-08-22 | — | — | US | disclosed |
| US-20160355492-A1 | Methods of Making Sulfurized Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-12-08 | — | — | US | disclosed |
| CN-103562362-B | The monomer of functionalization | 艾勒旺斯可再生科学公司 | 2016-09-14 | — | — | CN | disclosed |
| US-9334347-B2 | Functionalized monomers and polymers | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9012385-B2 | Terpene derived compounds | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-04-21 | — | — | US | disclosed |
| US-20140357539-A1 | FUNCTIONALIZED MONOMERS AND POLYMERS | WILMAR TRADING PTE LTD (SG) | 2014-12-04 | — | — | US | disclosed |
| US-20120283156-A1 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES | 2012-11-08 | — | — | US | disclosed |
| US-20120277133-A1 | FUNCTIONALIZED POLYMERS | ELEVANCE RENEWABLE SCIENCES, INC. | 2012-11-01 | — | — | US | disclosed |
| US-20120264662-A1 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES | 2012-10-18 | — | — | US | disclosed |
| US-20120264664-A1 | MALIENATED DERIVATIVES | WILMAR TRADING PTE LTD (SG) | 2012-10-18 | — | — | US | disclosed |
| WO-2012129490-A2 | FUNCTIONALIZED POLYMERS | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012128788-A1 | FUNCTIONALIZED MONOMERS AND POLYMERS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012129479-A2 | MALIENATED DERIVATIVES | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20120245063-A1 | FUNCTIONALIZED MONOMERS AND POLYMERS | WILMAR TRADING PTE LTD (SG) | 2012-09-27 | — | — | US | disclosed |
| WO-2012129477-A1 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012129482-A2 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES (US) | 2012-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120277133-A1 | FUNCTIONALIZED POLYMERS | PARG, PUF60, ADH1C | ALDH1A1 428/4885LMNA 2091/4885MAPT 655/4885 |
| US-20120264662-A1 | FUNCTIONALIZED MONOMERS | MEP1A, MLEC, ADH1A | ALDH1A1 83/4885LMNA 3186/4885MAPT 1894/4885 |
| US-20180111912-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | ALDH1A1 383/4885LMNA 1847/4885MAPT 1493/4885 |
| US-20120245063-A1 | FUNCTIONALIZED MONOMERS AND POLYMERS | PUF60, FGB, MSN | ALDH1A1 562/4885LMNA 2878/4885MAPT 1386/4885 |
| US-20190284152-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | ALDH1A1 383/4885LMNA 1847/4885MAPT 1493/4885 |
| US-20120283156-A1 | FUNCTIONALIZED MONOMERS | MEP1A, MLEC, ELANE | ALDH1A1 341/4885LMNA 2954/4885MAPT 3158/4885 |
| US-20160355492-A1 | Methods of Making Sulfurized Derivatives | GPX4, CBS, ESD | ALDH1A1 769/4885LMNA 4738/4885MAPT 2790/4885 |
| US-10294210-B2 | Maleinated derivatives | SMOX, SRM, PADI2 | ALDH1A1 385/4885LMNA 1892/4885MAPT 1538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.